Solid Biosciences (SLDB) Cash from Financing Activities (2017 - 2024)
Historic Cash from Financing Activities for Solid Biosciences (SLDB) over the last 7 years, with Q4 2024 value amounting to $6.9 million.
- Solid Biosciences' Cash from Financing Activities rose 127425.74% to $6.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $122.4 million, marking a year-over-year increase of 6272.64%. This contributed to the annual value of $122.4 million for FY2024, which is 382174.89% up from last year.
- Solid Biosciences' Cash from Financing Activities amounted to $6.9 million in Q4 2024, which was up 127425.74% from $3.3 million recorded in Q3 2024.
- Solid Biosciences' Cash from Financing Activities' 5-year high stood at $135.2 million during Q1 2021, with a 5-year trough of -$238000.0 in Q2 2021.
- In the last 4 years, Solid Biosciences' Cash from Financing Activities had a median value of $505000.0 in 2023 and averaged $25.6 million.
- Within the past 5 years, the most significant YoY rise in Solid Biosciences' Cash from Financing Activities was 11313787.88% (2022), while the steepest drop was 13333.33% (2022).
- Quarter analysis of 4 years shows Solid Biosciences' Cash from Financing Activities stood at $66000.0 in 2021, then surged by 113137.88% to $74.7 million in 2022, then crashed by 99.32% to $505000.0 in 2023, then surged by 1274.26% to $6.9 million in 2024.
- Its last three reported values are $6.9 million in Q4 2024, $3.3 million for Q3 2024, and $5.0 million during Q2 2024.